View profile

Health - Science & Fundraising must go on!

Hi there ! 😁 Alaedine's here. I hope that you and your family are safe 💪 ➡️ This week has been mainly
Issue #23 — View online — Suggest a link
Health
The latest news and information about innovations in healthcare.
Hi there ! 😁
Alaedine’s here. I hope that you and your family are safe 💪
➡️ This week has been mainly covid-focused regarding the news. It happens that the coronavirus rases four types of concerns/thoughts :
  1. Detection: it’s all the discussions around testing and tracing.
  2. Treatments: all the scientific papers around drugs like Remdesivir, Hydroxychloroquine, etc.
  3. Vaccine: when and how.
  4. The after: will we come back to a similar before-covid state? Or can we change for the best?
▶️ We triied here to summarize some of the main news. Google just released a publication about the use of a Deep Learning system deployment. Another publication, in Heart Rythm, underlines the importance of wearables in cardiology. The last article shows an algorithm that can (more or less) predict the next disease of a patient based on its EHR.
Wish you great week 🎊,
-Alaedine

What about science?
Each week, we curate some scientific articles that introduce a disrupting innovation or a worth-reading opinion.
A Human-Centered Evaluation of a Deep Learning System Deployed in Clinics for the Detection of Diabetic Retinopathy
A research by a Google team. Very interesting to read!
Doing AI is good. Making a product is great. Integrate it successfully to the clinical workflow is the best.
Read now  |  Share
Wearables in cardiology: Here to stay - Heart Rhythm
Wearables in cardiology: Here to stay - Heart Rhythm
With the ongoing development of new features capable of assessing real-time biometric data, the impact of wearables on cardiovascular management has become inevitable.
Read now  |  Share
BEHRT: Transformer for Electronic Health Records | Scientific Reports
BEHRT: Transformer for Electronic Health Records | Scientific Reports
Early indication and detection of diseases, however, can provide patients and carers with the chance of early intervention, better disease management, and efficient allocation of healthcare resources.
Read now  |  Share
Week's hot trends and impacts (aka Covid)
Thoughts on testing and treating + the after-crisis. Bonus: a really good fiction novel.
Johns Hopkins launches COVID-19 testing hub to provide public access to testing data – TechCrunch
Johns Hopkins launches COVID-19 testing hub to provide public access to testing data – TechCrunch
The COVID-19 testing picture in the U.S. is far from easy to understand, given the disparate agencies and public and private health organizations involved.
Read now  |  Share
Hopes rise for coronavirus drug remdesivir
Hopes rise for coronavirus drug remdesivir
Despite conflicting studies, results from largest trial yet show the antiviral speeds up recovery, putting it on track to become a standard of care in the United States.
Read now  |  Share
Will the Coronavirus Create a More Progressive Society or a More Dystopian One? | The New Yorker
Will the Coronavirus Create a More Progressive Society or a More Dystopian One? | The New Yorker
Demagogues have to be defeated, during pandemics more than ever.
Read now  |  Share
“The Wish for a Good Young Country Doctor,” by Allan Gurganus | The New Yorker
“The Wish for a Good Young Country Doctor,” by Allan Gurganus | The New Yorker
Fiction by Allan Gurganus: “The doctor was soon the only person brave or fool enough to duck under the orange quarantine ropes, ignoring warning signs he himself had nailed to the doors of those farmhouses worst hit.”
Read now  |  Share
For VCs
Some of the biggest fundraising/acquisition of the week.
Erasca Raises $200 Million Series B Financing | Business Wire
Erasca, a company whose mission is to erase cancer, announced the completion of a $200 million Series B.
Read now  |  Share
Compass raises $80M to take magic mushroom drug toward phase 3 | FierceBiotech
Compass raises $80M to take magic mushroom drug toward phase 3 | FierceBiotech
The aim is to prepare its psilocybin therapy for phase 3 development. The London-based biotech is advancing the drug, the active ingredient in magic mushrooms, for use in people with treatment-resistant depression.
Read now  |  Share
Medical robotics has an incredible future: French startup Robocath secures €40M funding to deploy operations | Silicon Canals
Medical robotics has an incredible future: French startup Robocath secures €40M funding to deploy operations | Silicon Canals
Medical robotics startup based in France, Robocath has secured funding from MicroPort to expand its presence in Asian markets.
Read now  |  Share
Dascena Secures $50M Series B To Improve Patient Outcomes – Crunchbase News
Dascena Secures $50M Series B To Improve Patient Outcomes – Crunchbase News
Dascena’s flagship sepsis algorithm, InSight, has helped reduce the number of deaths by 58 percent and decrease the length of hospital stay by 21 percent, in patients with sepsis.
Read now  |  Share
Book of the week
The ONE Thing by Gary Keller and Jay Papasan
The ONE Thing by Gary Keller and Jay Papasan
The ONE Thing: The Surprisingly Simple Truth Behind Extraordinary Results is a non-fiction, self-help book written by authors and real estate entrepreneurs, Gary W. Keller and Jay Papasan.
The book discusses the value of simplifying one’s workload by focusing on the one most important task in any given project.
The book has appeared on the best seller lists of The New York Times, The Wall Street Journal, USA Today, and Amazon.com.
Read now  |  Share
Techstars Startup Digest Health is curated by:
Alaedine Benani Alaedine Benani - MD PhD Trainee - MSc in Data Science & Entrepreneurship
alaedine.benani@startupdigestmail.com
Did you enjoy this issue?
Did you see something you think we should include in our newsletter? Suggest a link.
Manage all your newsletter subscriptions here.
If you were forwarded this newsletter and you like it, you can subscribe here.
If you don’t want to receive this newsletter anymore, unsubscribe here.
Powered by Revue